Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2013 | (FY)Dec 30, 2011 | (FY)Dec 30, 2010 | (Q3)Sep 30, 2009 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.38K | 82.77M | 30.77%47.98M | 36.69M | 2.41M | |||
| Operating revenue | --10.38K | ---- | ---- | ---- | --82.77M | 30.77%47.98M | --36.69M | --2.41M |
| Cost of revenue | 43.64M | 58.22%20.91M | 13.21M | 2.08M | ||||
| Gross profit | 10.38K | 39.13M | 15.32%27.07M | 23.47M | 330.25K | |||
| Operating expense | 208.35%30.3M | 718.92%9.83M | -65.17%1.2M | 3.44M | 34.46M | 36.27%26.31M | 19.3M | 2.28M |
| Selling and administrative expenses | 30.52%4.16M | 165.50%3.18M | -64.73%1.2M | --3.4M | --8.64M | 18.34%12.23M | --10.33M | --1.59M |
| -General and administrative expense | 30.52%4.16M | 165.50%3.18M | -64.73%1.2M | --3.4M | --8.64M | 18.34%12.23M | --10.33M | --1.59M |
| Depreciation amortization depletion | 345.84%130K | 5,987.47%29.16K | -96.48%479 | --13.6K | --20.75M | 49.44%13.41M | --8.97M | --657.87K |
| -Depreciation and amortization | 345.84%130K | 5,987.47%29.16K | -96.48%479 | --13.6K | --20.75M | 49.44%13.41M | --8.97M | --657.87K |
| Other operating expenses | 293.38%26.01M | --6.61M | ---- | --30.08K | --5.07M | --669.12K | ---- | --34.56K |
| Operating profit | -208.25%-30.29M | -718.92%-9.83M | 65.17%-1.2M | -3.44M | 4.67M | -81.66%764.44K | 4.17M | -1.95M |
| Net non-operating interest income (expenses) | -80.72%-8.18M | -65,273.24%-4.53M | 103.17%6.95K | -219.2K | -10.81M | -460.82%-7.18M | -1.28M | 7.87K |
| Non-operating interest income | -18.02%85.15K | 1,252.81%103.87K | 15,895.83%7.68K | --48 | ---- | ---- | --40.84K | ---- |
| Non-operating interest expense | 78.51%8.27M | 633,477.84%4.63M | -99.67%731 | --219.25K | --10.81M | 443.48%7.18M | --1.32M | ---- |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7.87K |
| Other net income (expenses) | -100.50%-3.88K | 1,824.22%779.43K | 112.64%40.51K | -320.46K | -17.46M | 323.07%12.24M | -5.49M | 39.05K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---17.47M | ---- | ---- | --39.05K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | --3.44M | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | --14.03M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -100.50%-3.88K | 1,824.22%779.43K | 112.64%40.51K | ---320.46K | --2.08K | 323.07%12.24M | ---5.49M | ---- |
| Income before tax | -183.44%-38.47M | -1,077.90%-13.57M | 71.08%-1.15M | -3.98M | -23.61M | 324.10%5.83M | -2.6M | |
| Income tax | 0 | 0 | 0 | 0 | 1.7M | 85.40%4.18M | 2.25M | |
| Earnings from equity interest net of tax | ||||||||
| Net income | -183.44%-38.47M | -1,077.90%-13.57M | 71.08%-1.15M | -3.98M | -25.3M | 133.89%1.64M | -4.85M | |
| Net income continuous operations | -183.44%-38.47M | -1,077.90%-13.57M | 71.08%-1.15M | ---3.98M | ---25.3M | 133.89%1.64M | ---4.85M | ---- |
| Noncontrolling interests | -967.62%-1.71M | -13,334.26%-160K | -1.19K | -2.05M | -30.56%560.25K | 806.79K | ||
| Net income attributable to the company | -174.08%-36.76M | -1,065.22%-13.41M | 71.11%-1.15M | -3.98M | -23.25M | 119.16%1.08M | -5.66M | |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | ||||||||
| Net income attributable to common stockholders | -174.08%-36.76M | -1,065.22%-13.41M | 71.11%-1.15M | -3.98M | -23.25M | 119.16%1.08M | -5.66M | |
| Diluted earnings per share | -174.69%-0.0879 | -869.70%-0.032 | 81.40%-0.0033 | -0.0177 | -0.0601 | 116.86%0.0029 | -0.017 | |
| Basic earnings per share | -174.69%-0.0879 | -869.70%-0.032 | 81.40%-0.0033 | -0.0177 | -0.0601 | 116.86%0.0029 | -0.017 | |
| Dividend per share | ||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |